KJ

Kamalahmad Jalalahmed Khan

Active Director Director DIN 00814566
DIN 00814566 First appointment Sep 2007 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Kamalahmad Jalalahmed Khan

Data last updated:

Kamalahmad Jalalahmed Khan is a Director at Deevyalok Pharma Private Limited (since 2007). The company operates in Pharma.

DIN 00814566
Primary Designation Director
Industry Pharma
First Appointment 18 Sep 2007
Oldest Company Age 42 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Deevyalok Pharma Private Limited U24100MH1984PTC032423
Director18 Sep 20071984Active

Directorship timeline

Open interactive timeline →
Deevyalok Pharma Private Limited
Premium access

Shareholding and investment profile for Kamalahmad Jalalahmed Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamalahmad Jalalahmed Khan

Kamalahmad Jalalahmed Khan currently holds 1 directorship: Deevyalok Pharma Private Limited (Director, since 18 Sep 2007).

Kamalahmad Jalalahmed Khan was first appointed on 18 Sep 2007 as Director at Deevyalok Pharma Private Limited.

The current boards of Kamalahmad Jalalahmed Khan's companies include Chhailbihari Ramlagan Upadhyay (Deevyalok Pharma Private Limited), Haresh Budhia Machhi (Deevyalok Pharma Private Limited), Kamlesh Ramubhai Jaiswal (Deevyalok Pharma Private Limited), Vimal Upadhyay (Deevyalok Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available